Impact Factor
3.70
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.48
1,036 total citations
h5-index
42
h5 depth signal
Cited share
78.6%
246 of 313
Total citations
1,036
Citation footprint
Metric signal
3.33
External metric anchor
Self-citation
3.8%
39 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
647
China
346
United Kingdom
123
Australia
120
Italy
117
Citing Fields of Research
Diabetes
1,703
Kidney Diseases
217
Cardiology
163
Urology
113
Ophthalmology
107
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,031
Articles tracked across the journal lifetime
Indexed publication set
313
246 cited publications
Last 12 months
126
10.5 publications/month
Open access share
38.9%
49 OA publications in the last year
Leading citing country
United States
647 citing publications
Leading citing field
Diabetes
1,703 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v6n1,Jan.-Mar. 1992-
v6n1,Jan.-Mar. 1992-
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Broad Categories
Endocrinology
Diabetes
MeSH Descriptors
Diabetes Complications
Diabetes Mellitus
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.jdiacomp.2026.109438
Open DOI
Artificial intelligence in diabetes: Clinical applications across the disease continuum
02
03
DOI 10.1016/j.jdiacomp.2026.109437
Open DOI
SGLT2 inhibitors in diabetic biopsy proven MASH patients: A systematic review and meta-analysis
04
DOI 10.1016/j.jdiacomp.2026.109436
Open DOI
TNF-α, fasting insulin, and microRNA-192 as biomarkers of disease severity and complications in pediatric type 1 diabetes mellitus
05
DOI 10.1016/j.jdiacomp.2026.109435
Open DOI
Hyperglycemia-induced metabolic rewiring is associated with skeletal muscle loss in a fructose-streptozotocin-induced diabetic rat model
06
DOI 10.1016/j.jdiacomp.2026.109434
Open DOI
Optimizing foot screening in type 1 diabetes: Evaluation of risk-adapted screening intervals (OPTI-ONE)
07
DOI 10.1016/s1056-8727(26)00172-8
Open DOI
Contents/Barcode
08
DOI 10.1016/j.jdiacomp.2026.109421
Open DOI
Diabetic foot ulcers and their impact on foot care habits and quality of life
09
DOI 10.1016/j.jdiacomp.2026.109420
Open DOI
Age-related differences in renal function decline and associated factors in type 2 diabetes mellitus: A prospective cohort study
10
DOI 10.1016/j.jdiacomp.2026.109419
Open DOI
Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity
Bibliographical & Catalog Notes
Quarterly.
Title from cover.
Also available online.
Continues: Journal of diabetic complications.
Vol. 9, no. 1 (JAN-MAR 1995)19950516 Notice published Printed on acid-free paper